Cardiac involvement in systemic rheumatic diseases: An update

Turiel, 2010, The heart in rheumatoid arthritis, Autoimmun Rev, 9, 414, 10.1016/j.autrev.2009.11.002 Sitia, 2009, Cardiovascular involvement in systemic autoimmune diseases, Autoimmun Rev, 8, 281, 10.1016/j.autrev.2008.08.004 Del Rincon, 2001, High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors, Arthritis Rheum, 44, 2737, 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-# Nurmohamed, 2009, Cardiovascular risk in rheumatoid arthritis, Autoimmun Rev, 8, 663, 10.1016/j.autrev.2009.02.015 Shoenfeld, 2005, Accelerated atherosclerosis in autoimmune rheumatic diseases, Circulation, 112, 3337, 10.1161/CIRCULATIONAHA.104.507996 Montecucco, 2009, Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis, Rheumatology, 48, 11, 10.1093/rheumatology/ken395 Bartoloni, 2010, How early is the atherosclerotic risk in rheumatoid arthritis?, Autoimmun Rev, 9, 701, 10.1016/j.autrev.2010.06.001 Gerli, 2007, Precocious atherosclerosis in rheumatoid arthritis. Role of traditional and disease-related cardiovascular risk factors, Ann NY Acad Sci, 1108, 372, 10.1196/annals.1422.038 Bang, 2010, Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status, Arthritis Rheum, 62, 369 Gerli, 2008, Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis, Ann Rheum Dis, 67, 724, 10.1136/ard.2007.073718 Weng, 2009, CD28− T cells: their role in the age-associated decline of immune function, Trends Immunol, 30, 306, 10.1016/j.it.2009.03.013 Gerli, 2004, CD4+CD28− T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients, Circulation, 109, 2744, 10.1161/01.CIR.0000131450.66017.B3 Tyrrell, 2010, Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis, Arterioscler Thromb Vasc Biol, 30, 1014, 10.1161/ATVBAHA.109.198424 Gerli, 2009, Different roles for anti-cyclic citrullinated peptide antibodies and CD4+CD28null cells in the acceleration of atherosclerosis in rheumatoid, Arthritis Rheum, 60, 631, 10.1002/art.24297 Gerli, 2010, Functional impairment of the arterial wall in primary Sjögren's syndrome: combined action of immunologic and inflammatory factors, Arthritis Care Res (Hoboken), 62, 712, 10.1002/acr.20117 Kokkonen, 2010, Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis, Arthritis Rheum, 62, 383 Doria, 2005, Cardiac involvement in systemic lupus erythematosus, Lupus, 14, 683, 10.1191/0961203305lu2200oa Colombo, 2009, Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study), Autoimmun Rev, 8, 309, 10.1016/j.autrev.2008.10.002 Doria, 2006, Long-term prognosis and causes of death in systemic lupus erythematosus, Am J Med, 119, 1497, 10.1016/j.amjmed.2005.11.034 Turiel, 2005, Cardiac imaging techniques in systemic autoimmune diseases, Lupus, 14, 727, 10.1191/0961203305lu2209oa Doria, 2009, Atherosclerosis and lupus: what we know and what we should know, J Rheumatol, 36, 2380, 10.3899/jrheum.090999 Bizzarro, 2007, Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study, J Thromb Haemost, 5, 1158, 10.1111/j.1538-7836.2007.02532.x Doria, 2005, Inflammation and accelerated atherosclerosis — basic mechanisms, Rheum Dis Clin N Am, 31, 329, 10.1016/j.rdc.2005.01.006 Bassi, 2009, Pentraxins, anti-pentraxin antibodies, and atherosclerosis, Clin Rev Allergy Immunol, 37, 36, 10.1007/s12016-008-8098-6 Doria, 2004, Premature coronary disease in systemic lupus, N Eng J Med, 350, 1571, 10.1056/NEJM200404083501518 Doria, 2003, Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus, Ann Rheum Dis, 62, 1071, 10.1136/ard.62.11.1071 Doria, 2008, Primary prevention of systemic lupus erythematosus, Nat Clin Pract Rheumatol, 4, 576, 10.1038/ncprheum0899 Doria, 2008, Preventive strategies in systemic lupus erythematosus, Autoimmun Rev, 7, 192, 10.1016/j.autrev.2007.11.004 Doria, 2008, Lupus: improving long-term prognosis, Lupus, 17, 166, 10.1177/0961203307087612 Guiducci, 2007, Vascular complications of scleroderma, Autoimmune Rev, 6, 520, 10.1016/j.autrev.2006.12.006 Kahan, 2006, Primary myocardial involvement in systemic sclerosis, Rheumatology, 45, 14, 10.1093/rheumatology/kel312 Kaloudi, 2009, Systemic sclerosis: the heart puzzle, Rheumatologist, 3, 13 Anvari, 1992, Cardiac involvement in systemic sclerosis, Arthritis Rheum, 35, 1356, 10.1002/art.1780351117 De Subitaneis Mortibus, 1974, Coronary arteries and conduction system in scleroderma heart disease, Circulation, 50, 844, 10.1161/01.CIR.50.4.844 Bukley, 1976, Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction, Circulation, 53, 483, 10.1161/01.CIR.53.3.483 Kostis, 1988, Prognostic importance of cardiac arrhythmias in systemic sclerosis, Am J Med, 84, 1007, 10.1016/0002-9343(88)90305-1 Martinez-Taboada, 1994, Malignant ventricular arrhythmia in systemic sclerosis controlled with an implantable cardioverter defibrillator, J Rheumatol, 21, 2166 Long, 1986, Reversible myocardial perfusion defects during cold challenge in scleroderma, Br J Rheumatol, 25, 158, 10.1093/rheumatology/25.2.158 Follansbee, 1993, Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma):a high risk association, Am Heart J, 125, 194, 10.1016/0002-8703(93)90075-K Bernardo P., Conforti M.L., Bellando-Randone S., Pieragnoli P., Blagojevic J., Kaloudi O., et al Implantable cardioverter defibrillator prevent sudden cardiac death in Systemic Sclerosis. Submitted.